Literature DB >> 7991590

Angiogenin promotes invasiveness of cultured endothelial cells by stimulation of cell-associated proteolytic activities.

G Hu1, J F Riordan, B L Vallee.   

Abstract

Angiogenin, a potent inducer of neovascularization in the chicken chorioallantoic membrane and rabbit cornea, promotes endothelial cell invasion of Matrigel basement membrane. A transformed bovine aortic endothelial cell line, GM 7373, is 5 times more invasive when cultured in the presence of 1 microgram of bovine angiogenin per ml than in its absence. A polyclonal anti-angiogenin antibody and alpha 2-antiplasmin neutralize the effect of angiogenin, but an angiogenin-binding protein (actin) does not. Further, this concentration of angiogenin induces a 14-fold increase in the cell-associated proteolytic activity of cultured endothelial cells, determined with a tissue-type plasminogen activator-specific peptide as the substrate. In addition, cells cultured on a three-dimensional fibrin gel in the presence of angiogenin are 3 times more capable of dissolving the gel and forming focal defects in the underlying matrix. The results indicate that angiogenin can enhance the ability of endothelial cells to digest extracellular matrix components and degrade basement membrane, thereby facilitating cell invasion and migration. Binding of angiogenin to its cell-surface binding protein (actin) followed by dissociation of the angiogenin-actin complex from the cell surface and subsequent activation of tissue-type plasminogen activator/plasmin are likely steps involved in the processes of endothelial cell invasion and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7991590      PMCID: PMC45383          DOI: 10.1073/pnas.91.25.12096

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

Review 1.  Angiogenic factors.

Authors:  J Folkman; M Klagsbrun
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

2.  Characteristic ribonucleolytic activity of human angiogenin.

Authors:  R Shapiro; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1986-06-17       Impact factor: 3.162

3.  Tissue distribution and developmental expression of the messenger RNA encoding angiogenin.

Authors:  H L Weiner; L H Weiner; J L Swain
Journal:  Science       Date:  1987-07-17       Impact factor: 47.728

Review 4.  Plasminogen activator inhibitors--a review.

Authors:  E K Kruithof
Journal:  Enzyme       Date:  1988

5.  Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells.

Authors:  J W Fett; D J Strydom; R R Lobb; E M Alderman; J L Bethune; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

6.  Amino acid sequence of human tumor derived angiogenin.

Authors:  D J Strydom; J W Fett; R R Lobb; E M Alderman; J L Bethune; J F Riordan; B L Vallee
Journal:  Biochemistry       Date:  1985-09-24       Impact factor: 3.162

7.  Angiogenin mRNA in human tumor and normal cells.

Authors:  S M Rybak; J W Fett; Q Z Yao; B L Vallee
Journal:  Biochem Biophys Res Commun       Date:  1987-08-14       Impact factor: 3.575

8.  Long-term culture of capillary endothelial cells.

Authors:  J Folkman; C C Haudenschild; B R Zetter
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

Review 9.  Fibrin as a component of the tumor stroma: origins and biological significance.

Authors:  H F Dvorak; D R Senger; A M Dvorak
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

10.  Human angiogenin, an organogenic protein.

Authors:  J F Riordan; B L Vallee
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

View more
  45 in total

1.  Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats.

Authors:  Jieli Chen; Xinchun Ye; Tao Yan; Chunling Zhang; Xiao-Ping Yang; Xu Cui; Yishen Cui; Alex Zacharek; Cynthia Roberts; Xinfeng Liu; Xiangguo Dai; Mei Lu; Michael Chopp
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

2.  Human angiogenin presents neuroprotective and migration effects in neuroblastoma cells.

Authors:  Goang-Won Cho; Byung Yong Kang; Seung Hyun Kim
Journal:  Mol Cell Biochem       Date:  2010-02-20       Impact factor: 3.396

3.  A neuroprotective role for angiogenin in models of Parkinson's disease.

Authors:  Trent U Steidinger; David G Standaert; Talene A Yacoubian
Journal:  J Neurochem       Date:  2010-12-22       Impact factor: 5.372

4.  Angiogenin interacts with the plasminogen activation system at the cell surface of breast cancer cells to regulate plasmin formation and cell migration.

Authors:  Sujoy Dutta; Chirosree Bandyopadhyay; Virginie Bottero; Mohanan V Veettil; Lydia Wilson; Michael R Pins; Karen E Johnson; Case Warshall; Bala Chandran
Journal:  Mol Oncol       Date:  2014-01-04       Impact factor: 6.603

Review 5.  A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

Authors:  B A Teicher
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

Review 6.  New insights into the role of angiogenin in actin polymerization.

Authors:  Mikhail G Pyatibratov; Alla S Kostyukova
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

7.  Neamine induces neuroprotection after acute ischemic stroke in type one diabetic rats.

Authors:  R Ning; M Chopp; A Zacharek; T Yan; C Zhang; C Roberts; M Lu; J Chen
Journal:  Neuroscience       Date:  2013-11-08       Impact factor: 3.590

8.  Neomycin inhibits angiogenin-induced angiogenesis.

Authors:  G F Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

Review 9.  Targeting angiogenin in therapy of amyotropic lateral sclerosis.

Authors:  Hiroko Kishikawa; David Wu; Guo-fu Hu
Journal:  Expert Opin Ther Targets       Date:  2008-10       Impact factor: 6.902

10.  Ribonuclease inhibitor regulates neovascularization by human angiogenin.

Authors:  Kimberly A Dickson; Dong-Ku Kang; Young Sam Kwon; Jae Chan Kim; Peter A Leland; Byung-Moon Kim; Soo-Ik Chang; Ronald T Raines
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.